The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist

Joelle E. Taylor, Bradley T. Miller, Karen D. Gray, Richard T. Scott, William H. Catherino, James Segars

Research output: Contribution to journalArticle

Abstract

Objective: To elucidate the physiologic mechanism responsible for the supraphysiologic gonadotropin release from the pituitary induced by gonadotropin-releasing hormone (GnRH) agonist in female rats primed with GnRH antagonist. Design: Controlled experimental intervention. Setting: Government research facility. Animal(s): Forty 8-week-old Sprague-Dawley rats. Intervention(s): Forty oophorectomized rats were randomized into four treatment groups of 10: group A, control vehicles; group B, GnRH agonist (leuprolide acetate; 1.7 μg/kg twice a day) on day 4; group C, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4; or group D, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4 plus GnRH agonist (1.7 μg/kg twice a day) on day 4. Main Outcome Measure(s): Immunohistochemical methods, Northern and in situ hybridization to quantitate pituitary follicle-stimulating hormone beta (FSH-β), luteinizing hormone beta (LH-β), and GnRH receptor (GnRH-R) messenger RNA (mRNA), and receptor protein levels in all treatment groups. Result(s): Treatment with GnRH antagonist was associated with increased storage of gonadotropin in the pituitary for FSH-β and LH-β, but mRNA levels were unchanged. The GnRH-R mRNA decreased after GnRH-agonist treatment but remained stable in the GnRH-antagonist treatment groups. Levels of GnRH-R were decreased after GnRH-antagonist treatment. Conclusion(s): These data indicate that the in vivo mechanism responsible for the exaggerated release of gonadotropins in rats primed with GnRH antagonist and treated with GnRH agonist was an increase in releasable gonadotropin pools coupled with a reduction in GnRH-R, but receptor function was preserved.

Original languageEnglish (US)
Pages (from-to)1668-1675
Number of pages8
JournalFertility and Sterility
Volume93
Issue number5
DOIs
StatePublished - Mar 15 2010
Externally publishedYes

Fingerprint

Hormone Antagonists
Gonadotropins
Gonadotropin-Releasing Hormone
LHRH Receptors
Pituitary Gonadotropins
Messenger RNA
Leuprolide
Pituitary Hormones
Follicle Stimulating Hormone
Luteinizing Hormone

Keywords

  • GnRH receptor
  • LH surge
  • LH-RH
  • OHSS
  • ovarian hyperstimulation syndrome
  • ovulation induction
  • pituitary

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist. / Taylor, Joelle E.; Miller, Bradley T.; Gray, Karen D.; Scott, Richard T.; Catherino, William H.; Segars, James.

In: Fertility and Sterility, Vol. 93, No. 5, 15.03.2010, p. 1668-1675.

Research output: Contribution to journalArticle

Taylor, Joelle E. ; Miller, Bradley T. ; Gray, Karen D. ; Scott, Richard T. ; Catherino, William H. ; Segars, James. / The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist. In: Fertility and Sterility. 2010 ; Vol. 93, No. 5. pp. 1668-1675.
@article{327d712d4b244458b648d85be36ad566,
title = "The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist",
abstract = "Objective: To elucidate the physiologic mechanism responsible for the supraphysiologic gonadotropin release from the pituitary induced by gonadotropin-releasing hormone (GnRH) agonist in female rats primed with GnRH antagonist. Design: Controlled experimental intervention. Setting: Government research facility. Animal(s): Forty 8-week-old Sprague-Dawley rats. Intervention(s): Forty oophorectomized rats were randomized into four treatment groups of 10: group A, control vehicles; group B, GnRH agonist (leuprolide acetate; 1.7 μg/kg twice a day) on day 4; group C, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4; or group D, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4 plus GnRH agonist (1.7 μg/kg twice a day) on day 4. Main Outcome Measure(s): Immunohistochemical methods, Northern and in situ hybridization to quantitate pituitary follicle-stimulating hormone beta (FSH-β), luteinizing hormone beta (LH-β), and GnRH receptor (GnRH-R) messenger RNA (mRNA), and receptor protein levels in all treatment groups. Result(s): Treatment with GnRH antagonist was associated with increased storage of gonadotropin in the pituitary for FSH-β and LH-β, but mRNA levels were unchanged. The GnRH-R mRNA decreased after GnRH-agonist treatment but remained stable in the GnRH-antagonist treatment groups. Levels of GnRH-R were decreased after GnRH-antagonist treatment. Conclusion(s): These data indicate that the in vivo mechanism responsible for the exaggerated release of gonadotropins in rats primed with GnRH antagonist and treated with GnRH agonist was an increase in releasable gonadotropin pools coupled with a reduction in GnRH-R, but receptor function was preserved.",
keywords = "GnRH receptor, LH surge, LH-RH, OHSS, ovarian hyperstimulation syndrome, ovulation induction, pituitary",
author = "Taylor, {Joelle E.} and Miller, {Bradley T.} and Gray, {Karen D.} and Scott, {Richard T.} and Catherino, {William H.} and James Segars",
year = "2010",
month = "3",
day = "15",
doi = "10.1016/j.fertnstert.2008.12.047",
language = "English (US)",
volume = "93",
pages = "1668--1675",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist

AU - Taylor, Joelle E.

AU - Miller, Bradley T.

AU - Gray, Karen D.

AU - Scott, Richard T.

AU - Catherino, William H.

AU - Segars, James

PY - 2010/3/15

Y1 - 2010/3/15

N2 - Objective: To elucidate the physiologic mechanism responsible for the supraphysiologic gonadotropin release from the pituitary induced by gonadotropin-releasing hormone (GnRH) agonist in female rats primed with GnRH antagonist. Design: Controlled experimental intervention. Setting: Government research facility. Animal(s): Forty 8-week-old Sprague-Dawley rats. Intervention(s): Forty oophorectomized rats were randomized into four treatment groups of 10: group A, control vehicles; group B, GnRH agonist (leuprolide acetate; 1.7 μg/kg twice a day) on day 4; group C, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4; or group D, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4 plus GnRH agonist (1.7 μg/kg twice a day) on day 4. Main Outcome Measure(s): Immunohistochemical methods, Northern and in situ hybridization to quantitate pituitary follicle-stimulating hormone beta (FSH-β), luteinizing hormone beta (LH-β), and GnRH receptor (GnRH-R) messenger RNA (mRNA), and receptor protein levels in all treatment groups. Result(s): Treatment with GnRH antagonist was associated with increased storage of gonadotropin in the pituitary for FSH-β and LH-β, but mRNA levels were unchanged. The GnRH-R mRNA decreased after GnRH-agonist treatment but remained stable in the GnRH-antagonist treatment groups. Levels of GnRH-R were decreased after GnRH-antagonist treatment. Conclusion(s): These data indicate that the in vivo mechanism responsible for the exaggerated release of gonadotropins in rats primed with GnRH antagonist and treated with GnRH agonist was an increase in releasable gonadotropin pools coupled with a reduction in GnRH-R, but receptor function was preserved.

AB - Objective: To elucidate the physiologic mechanism responsible for the supraphysiologic gonadotropin release from the pituitary induced by gonadotropin-releasing hormone (GnRH) agonist in female rats primed with GnRH antagonist. Design: Controlled experimental intervention. Setting: Government research facility. Animal(s): Forty 8-week-old Sprague-Dawley rats. Intervention(s): Forty oophorectomized rats were randomized into four treatment groups of 10: group A, control vehicles; group B, GnRH agonist (leuprolide acetate; 1.7 μg/kg twice a day) on day 4; group C, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4; or group D, GnRH antagonist (Nal-Lys; 3 mg/kg each day) days 1 to 4 plus GnRH agonist (1.7 μg/kg twice a day) on day 4. Main Outcome Measure(s): Immunohistochemical methods, Northern and in situ hybridization to quantitate pituitary follicle-stimulating hormone beta (FSH-β), luteinizing hormone beta (LH-β), and GnRH receptor (GnRH-R) messenger RNA (mRNA), and receptor protein levels in all treatment groups. Result(s): Treatment with GnRH antagonist was associated with increased storage of gonadotropin in the pituitary for FSH-β and LH-β, but mRNA levels were unchanged. The GnRH-R mRNA decreased after GnRH-agonist treatment but remained stable in the GnRH-antagonist treatment groups. Levels of GnRH-R were decreased after GnRH-antagonist treatment. Conclusion(s): These data indicate that the in vivo mechanism responsible for the exaggerated release of gonadotropins in rats primed with GnRH antagonist and treated with GnRH agonist was an increase in releasable gonadotropin pools coupled with a reduction in GnRH-R, but receptor function was preserved.

KW - GnRH receptor

KW - LH surge

KW - LH-RH

KW - OHSS

KW - ovarian hyperstimulation syndrome

KW - ovulation induction

KW - pituitary

UR - http://www.scopus.com/inward/record.url?scp=77949264357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949264357&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2008.12.047

DO - 10.1016/j.fertnstert.2008.12.047

M3 - Article

C2 - 19200975

AN - SCOPUS:77949264357

VL - 93

SP - 1668

EP - 1675

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -